ResearchCrossroads connects academia, research foundations and the pharmaceutical industry in ways never before possible
Past News ReleasesRSS
San Mateo, CA (PRWEB) September 17, 2007
Innolyst, Inc., a leading provider of collaboration tools for not-for-profit medical research, today announced the launch of its ResearchCrossroads website at http://www.researchcrossroads.com. Recognizing a need to reduce redundant efforts in the nearly $200 billion of public research performed in the U.S. over the past 15 years by 125,000 researchers at 10,000 organizations, Innolyst created ResearchCrossroads to consolidate medical research from both government and private foundations and combine this with grants and funding opportunities, with an aim of speeding the discovery of treatments.
“ResearchCrossroads connects academia, research foundations and the pharmaceutical industry in ways never before possible,” says Kyle Brown, Founder of ResearchCrossroads. “Often, scientists are conducting research that may be useful in other diseases, but there is little information sharing today. For example, many neurological disease foundations are struggling with how to deliver treatments effectively to the brain. ResearchCrossroads connects those scientists and organizations working on similar research, speeding discovery.”
Since the passing of the Freedom of Information Act, the United States Government has been required to make federally funded research data available to the public. However, the format and accessibility of this information has made it nearly impossible to understand who is working on what research and how much is being funded. Now ResearchCrossroads consolidates data from government sources, including: NIH CRISP, NIH funding data, ClinicalTrials.gov and Grants.gov, and combines this information with grants and funding opportunities from private research foundations to present a comprehensive view of public medical research.
“We have over 125,000 researcher profiles, one million grants, and funding history for more than 10,000 organizations. This social network of scientists can annotate their research, providing more complete and accurate data so funding agencies can identify research partners,” continues Brown. “And foundations can leverage the outstanding work conducted by other organizations, making their valuable research dollars go farther.”
The consolidated information in ResearchCrossroads is used to create organization and researcher profiles. These intelligent profiles enable researchers, foundations and for-profit companies to quickly identify collaborators in specific disease areas, reducing redundant research and speeding the discovery of potential treatments. Researchers can update their profiles with biographies, publications, and photos to create a social network of researchers and organizations with similar research interests.
ResearchCrossroads is free to the public and foundations. Subscriptions to the data and analytical reporting are available to for-profit companies, highlighting not-for-profit research to potential commercial partners.
ResearchCrossroads manages the world’s not-for-profit research. By consolidating data from government sources and combining this information with grants and funding opportunities from private research foundations, ResearchCrossroads presents the most complete view of publicly funded medical research.
pr @ researchcrossroads.com